Home  /  Resource Library  /  Obinutuzumab (GA101) in Combination with Pixantrone for the Treatment of Patients with Relapsed Aggressive B-Cell Lymphoma: A Phase II Trial (GOAL)

Obinutuzumab (GA101) in Combination with Pixantrone for the Treatment of Patients with Relapsed Aggressive B-Cell Lymphoma: A Phase II Trial (GOAL)

Results of a phase II trial investigating Obinutuzumab in combination with Pixantrone for relapsed aggressive B-cell lymphoma.